Latest News

Hepatitis C, HIV Drugs Remain Number One in Outpatient Medicaid Spending
Kaiser Family Foundation analysis examines Medicaid outpatient prescription drug utilization and spending before rebates.
Study finds that hepatocytes cells respond to inflammation by activating a protein that creates the environment needed for cancer cells to spread.
Top news of the day from across the health care industry.
Eric Dallara, RPh, pharmacist for the New England Cancer Specialists explains the current challenges in the industry, especially regarding payment plans and payment reform during the National Community Oncology Dispensing Association, Inc. in Denver, Colorado.
A recent study showed that flavonoid-rich cocoa improved fatigue by 45% in patients with relapsing and remitting multiple sclerosis.
Celgene Corporation’s lenalidomide (Revlimid) is a targeted therapy that stops the growth of myeloma cells in the bone marrow.
This proposal, outlined by the Centers for Medicare & Medicaid Services (CMS) in late 2018, would undermine CMS’ stated goal of prioritizing value and improved patient outcomes over utilization and sickness.
If an assessment of risk is not conducted and implemented on a specific hazardous drug or dosage form, it must be handled according to the standard.

Features

Going Beyond the Prescription in Specialty Pharmacy
A data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.
The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.
Failure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.
The value of big data in health care is realized when raw data are transformed into insights that drive practice change and decision making.

Featured Company Profile

 
MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy

Videos

Eric Dallara, RPh, pharmacist for the New England Cancer Specialists explains the current challenges in the industry, especially regarding payment plans and payment reform during the National Community Oncology Dispensing Association, Inc. in Denver, Colorado.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA discusses the emerging influence of NCODA chemotherapy education and standardization process for healthcare providers, healthcare systems, and patients.

Cheryl Allen, BSPharm, MBA, Vice President of Industry Relations at Diplomat Pharmacy, talks about new therapeutic developments going on within the prostate cancer space.

Current Issue

March/April
Volume: 10
Number: 2

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$